Skip to Content

Q150 (Quetiapine Fumarate Extended-Release 150 mg)

Pill with imprint Q150 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 150 mg. It is supplied by Mallinckrodt Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Q150

Quetiapine Fumarate Extended-Release

Imprint
Q150
Strength
150 mg
Color
White
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mallinckrodt Inc.
National Drug Code (NDC)
00406-1181
Inactive Ingredients
lactose anhydrous, ethylcellulose (100 mPa.s), microcrystalline cellulose, hydroxyethyl cellulose (4000 mpa.s at 1%), magnesium stearate, lactose monohydrate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.